With the crystal structure of HDAC10 now in hand, the structure-based design of isozyme-specific inhibitors promises to open new avenues in studying the chemical biology of autophagy as well as the treatment of advanced-stage cancers in which this PDAC is implicated. The gene discussed is HDAC10; the disease is cancer.